Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72640 record(s)

Req # A-2019-002066

Adverse Reaction Report (AER) for PANTOPRAZOLE SODIUM. Report number: E2B_02876145.

Organization: Health Canada

8 page(s)
May 2020

Req # A-2019-002069

Adverse Reaction Report (AER) for PANTOPRAZOLE MAGNESIUM. Report numbers: E2B_02897131, E2B_02882249.

Organization: Health Canada

131 page(s)
May 2020

Req # A-2020-000152

Adverse Reaction Report (AER). Report number: E2B_02851945.

Organization: Health Canada

15 page(s)
May 2020

Req # A-2019-002078

Adverse Reaction Report (AER) for GALLIUM (GA67) CITRATE INJECTION. Report number: E2B_02808876. AER for KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION. Report number: 000730509.

Organization: Health Canada

16 page(s)
May 2020

Req # A-2020-000027

Adverse Reaction Report (AER). Report number: E2B_02868923.

Organization: Health Canada

21 page(s)
May 2020

Req # A-2020-000039

Adverse Reaction Report (AER). Report numbers: 000734249, E2B_02925968, E2B_02931880.

Organization: Health Canada

23 page(s)
May 2020

Req # A-2020-000050

Adverse Reaction Report (AER) for DEXLANSOPRAZOLE. Report number: E2B_02969034.

Organization: Health Canada

40 page(s)
May 2020

Req # A-2020-000054

Adverse Reaction Report (AER) for ULORIC. Report number: 000735448.

Organization: Health Canada

11 page(s)
May 2020

Req # A-2020-000063

Adverse Reaction Report (AER). Report numbers: E2B_02928614, E2B_02934756, E2B_02951574.

Organization: Health Canada

51 page(s)
May 2020

Req # A-2020-000084

Adverse Reaction Report (AER). Report number: 000705709.

Organization: Health Canada

7 page(s)
May 2020
Date modified: